Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?

Volume: 17, Issue: 11, Pages: 2770 - 2771
Published: Jan 1, 2021
Abstract
Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et...
Paper Details
Title
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?
Published Date
Jan 1, 2021
Volume
17
Issue
11
Pages
2770 - 2771
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.